RECRUITING

Spinal Stimulation and Mobility Devices

Conditions

Cerebral Palsy Stroke Premature Birth Hypoxic-Ischemic Encephalopathy Periventricular Leukomalacia Pediatric Mobility Aids Assistive Technology Spinal Stimulation

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study will combine non-invasive spinal stimulation with mobility devices to examine the acute impact of the individual and combined effects of these innovative techniques on mobility in children with cerebral palsy.

Official Title

Transcutaneous Stimulation and Mobility Device Use for Individuals with Neurologic Conditions

Quick Facts

Study Start:2022-08-04

Study Completion:2025-12

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05520359

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years to 70 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD, ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* have a neurologic condition * are 4-70 years of age * have stable medical condition * can perform simple cued motor tasks and who can follow 2-3 step commands * who are volunteering to be involved in this study * can provide feedback on comfort and experience during lab visits	* have significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation. * have cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention * have a history of uncontrolled seizures * have unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities * are dependent on ventilation support * have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump) * have history of orthopedic surgery in lower extremities or neurosurgery that may be a confounding factor for interpretation of the results (such as tendon transfer, tendon or muscle lengthening for spasticity management, injection therapies to lower extremity muscles, etc.) in last 12 months * have established osteoporosis and taking medication for osteoporosis treatment. * have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.) * have active cancer

Inclusion Criteria

Exclusion Criteria

* have a neurologic condition
* are 4-70 years of age
* have stable medical condition
* can perform simple cued motor tasks and who can follow 2-3 step commands
* who are volunteering to be involved in this study
* can provide feedback on comfort and experience during lab visits

* have significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation.
* have cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention
* have a history of uncontrolled seizures
* have unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities
* are dependent on ventilation support
* have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump)
* have history of orthopedic surgery in lower extremities or neurosurgery that may be a confounding factor for interpretation of the results (such as tendon transfer, tendon or muscle lengthening for spasticity management, injection therapies to lower extremity muscles, etc.) in last 12 months
* have established osteoporosis and taking medication for osteoporosis treatment.
* have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
* have active cancer

Contacts and Locations

Study Contact

Katherine Steele, PHD

CONTACT

206-685-2390

kmsteele@uw.edu

Charlotte Caskey

CONTACT

864-207-1155

cdcaskey@uw.edu

Principal Investigator

Katherine Steele, PHD

PRINCIPAL_INVESTIGATOR

University of Washington

Study Locations (Sites)

University of Washington

Seattle, Washington, 98195

United States

Collaborators and Investigators

Sponsor: University of Washington

Katherine Steele, PHD, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-04

Study Completion Date2025-12

Study Record Updates

Study Start Date2022-08-04

Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

Pediatric
Mobility Aids
Assistive Technology
Spinal Stimulation

Additional Relevant MeSH Terms

Cerebral Palsy
Stroke
Premature Birth
Hypoxic-Ischemic Encephalopathy
Periventricular Leukomalacia